Inhibition of Shiga Toxin 2 for E. coli O157 Control: An In-Silico Study on Natural and Synthetic Compounds
The findings suggest that luteolin holds promise as a lead molecule for further development as a therapeutic agent against E. coli infections, warranting additional studies to validate its efficacy and safety.
Authors
- Isra Noor (ORCID: https://orcid.org/0000-0002-8793-5508)
- Muhammad Shaukat (ORCID: https://orcid.org/0000-0001-8635-8692)
- Zhongjing Su (ORCID: https://orcid.org/0000-0002-2180-605X)
- Warda Waheed (ORCID: https://orcid.org/0000-0003-0058-6294)
- Ashiq Ali (ORCID: https://orcid.org/0000-0003-4715-4464)
- Ziyi Ji
- Kaynaat Akbar
Institutions
- Shantou University (CN)
- Shantou University Medical College (CN)
- University of Faisalabad (PK)
- University of Agriculture Faisalabad (PK)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-02-07
- DOI
- https://doi.org/10.2174/0109298673363373250118144235
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00